So far, 2018 isn't turning out like shareholders of Aphria (NASDAQOTH: APHQF)and Emerald Health Therapeutics (NASDAQOTH: EMHTF)hoped. Aphria stock is down 45% year to date, while Emerald Health is down 16%. Several issues, including dilution caused by offering new shares and a delay in the legalization of recreational marijuana in Canada, have taken a toll on both stocks.
Better Marijuana Stock: Aphria vs. Emerald Health Therapeutics
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться